10
Participants
Start Date
June 30, 2011
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2012
V2R (Vasopressin 2 receptor)
All ten subjects were used as their own controls in this double-blind, randomized controlled trial assessing the effect of the V2R on sweat sodium concentration via use of a V2R blocker (antagonist), stimulator (agonist), against a placebo (drug naive state).
Oakland University, Rochester
Georgetown University
OTHER
Oakland University
OTHER